Amazon and Mark Cuban have entered the pharmaceutical industry. Will they disrupt things in a way that delivers more efficiency and value for Americans?
Paul
Pruitt
Paul Pruitt
Paul Pruitt has worked directly with self-funded employers for over a decade, specializing in compliance and risk management of health plans.
He has worked for several large employee benefit firms and currently is CEO of SHARx, where he works closely with benefit advisers all over the country providing unique approaches to address lowering the cost of medications for employers and their members.